GLP1 6MG

Description

Semaglutide is a synthetic analogue of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone involved in glucose metabolism. As a GLP-1 receptor agonist, Semaglutide mimics the effects of endogenous GLP-1, promoting insulin secretion and suppressing glucagon release in a glucose-dependent manner—a mechanism that helps lower blood sugar without causing hypoglycemia.

Beyond its well-established role in glycemic control, ongoing research has revealed that Semaglutide may provide additional health benefits. Preclinical and clinical studies suggest it may:

• Improve cardiovascular health, including blood pressure and lipid regulation
• Enhance liver function, particularly in cases of fatty liver disease or NASH
• Support lung function and reduce inflammation in pulmonary conditions
• Slow or mitigate the progression of neurodegenerative diseases, including Alzheimer’s disease

Semaglutide is also noted for its appetite-suppressing properties. It achieves this by delaying gastric emptying and reducing intestinal motility, which collectively promote earlier satiety and reduced food intake. These effects make it a candidate of growing interest in the study of obesity and metabolic disorders.

Semaglutide Structure

Source: PubChem

Sequence: HXEGTFTSDVSSYLEGQAAK-OH.steric diacid-EFIAWLVRGRG
Molecular Formula: C187H291N45O59
Molecular Weight: 4113.58 g/mol
PubChem CID: 56843331
CAS Number: 910463-68-2
Synonyms: Semaglutide, Oxempic, Rybelsus, NN9535